Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-23, Stock:ABT, The news for the past five days is as follows:
2018-02-15: NEWS1: A Snapshot Of Abbott Labs' Business.NEWS2: A Snapshot Of Abbott Labs' Business.NEWS3: Noteworthy ETF Outflows: IWB, MDT, UNP, ABT.NEWS4: Noteworthy ETF Outflows: IWB, MDT, UNP, ABT.NEWS5: Today’s Research Reports on Trending Tickers: Gilead Sciences and Abbott Laboratories.NEWS6: 7 ‘Strong Buy’ Stocks That Look Cheap Right Now.NEWS7: 7 ‘Strong Buy’ Stocks That Look Cheap Right Now.
2018-02-16: NEWS1: Abbott Laboratories (ABT) Files 10-K for the Fiscal Year Ended on December 31, 2017.NEWS2: Abbott Laboratories (NYSE:ABT): Does The -66.57% Earnings Decline Make It An Underperformer?.NEWS3: Abbott Laboratories Jumps After Boosting Quarterly Dividend.NEWS4: Boston Scientific’s 4Q17 Sales Exceeded Analysts’ Estimates.NEWS5: Abbott Laboratories Jumps After Boosting Quarterly Dividend.NEWS6: Abbott Laboratories Jumps After Boosting Quarterly Dividend.NEWS7: BSX’s Anticipated Lotus Valve Relaunch: Not before 2019.NEWS8: FDA Grants Agios' (AGIO) Leukemia Candidate Priority Review.NEWS9: FDA Grants Agios' (AGIO) Leukemia Candidate Priority Review.NEWS10: BSX Stock Regains Momentum after Its Recent Bearish Trend.NEWS11: Cardiovascular Systems Portfolio Solid, Competition Rife.NEWS12: Cardiovascular Systems Portfolio Solid, Competition Rife.NEWS13: Abbott Declares 377th Consecutive Quarterly Dividend.NEWS14: FDA Grants Agios&apos; (AGIO) Leukemia Candidate Priority Review.NEWS15: Did AbbVie, Inc. Just Become the Most Shareholder-Friendly Stock in America?.NEWS16: Did AbbVie, Inc. Just Become the Most Shareholder-Friendly Stock in America?.
2018-02-20: NEWS1: Healthcare costs to put more stress on the family budget.NEWS2: How Did JNJ’s Surgical Devices Segment Perform in 4Q17 and 2017?.NEWS3: US Tax Reform Impacted Boston Scientific’s Profits in 4Q17.NEWS4: Trial Tests FTC's Power to Referee Drugmakers' Fight Against Generics.NEWS5: Pacemakers Continue to Drag on BSX’s Rhythm Management Segment.
2018-02-21: NEWS1: There Are Better Options Than Medtronic PLC Stock.NEWS2: There Are Better Options Than Medtronic PLC Stock.NEWS3: Analysts’ Latest Recommendations on Boston Scientific Stock.NEWS4: Boston Scientific’s Updated 2018 Guidance: What’s in Store?.NEWS5: BSX’s Investment and Acquisition Option Agreement with Millipede.NEWS6: Trial Tests FTC’s Power to Referee Drug Makers’ Fight Against Generics.
2018-02-22: NEWS1: Abbott Laboratories: ABT Stock’s Wall Street Recommendations.NEWS2: Abbott Laboratories’ Breast Cancer Study with Angle.NEWS3: Abbott Laboratories’ LibreLink App in Europe.NEWS4: Abbott Laboratories’ 377th Consecutive Quarterly Dividend.NEWS5: [$$] Union claims success at start of strike by UK university lecturers.

Answer: Rise